De novo SCN1A mutations in Dravet syndrome and related epileptic encephalopathies are largely of paternal origin

Background Dravet syndrome is a severe infantile epileptic encephalopathy caused in approximately 80% of cases by mutations in the voltage gated sodium channel subunit gene SCN1A. The majority of these mutations are de novo. The parental origin of de novo mutations varies widely among genetic disorders and the aim of this study was to determine this for Dravet syndrome. Methods 91 patients with de novo SCN1A mutations and their parents were genotyped for single nucleotide polymorphisms (SNPs) in the region surrounding their mutation. Allele specific polymerase chain reaction (PCR) based on informative SNPs was used to separately amplify and sequence the paternal and maternal alleles to determine in which parental chromosome the mutation arose. Results The parental origin of SCN1A mutations was established in 44 patients for whom both parents were available and SNPs were informative. The mutations were of paternal origin in 33 cases and of maternal origin in the remaining 11 cases. De novo mutation of SCN1A most commonly, but not exclusively, originates from the paternal chromosome. The average age of parents originating mutations did not differ from that of the general population. Conclusions The greater frequency of paternally derived mutations in SCN1A is likely to be due to the greater chance of mutational events during the increased number of mitoses which occur during spermatogenesis compared to oogenesis, and the greater susceptibility to mutagenesis of the methylated DNA characteristic of sperm cells.

[1]  I. Scheffer,et al.  SCN1A duplications and deletions detected in Dravet syndrome: Implications for molecular diagnosis , 2009, Epilepsia.

[2]  S. Seri,et al.  Idiopathic Epilepsies with Seizures Precipitated by Fever and SCN1A Abnormalities , 2007, Epilepsia.

[3]  A. Hattersley,et al.  Origin of de novo KCNJ11 mutations and risk of neonatal diabetes for subsequent siblings. , 2007, The Journal of clinical endocrinology and metabolism.

[4]  I. Scheffer,et al.  The spectrum of SCN1A-related infantile epileptic encephalopathies. , 2007, Brain : a journal of neurology.

[5]  I. Scheffer,et al.  Severe myoclonic epilepsy of infancy (Dravet syndrome): Recognition and diagnosis in adults , 2006, Neurology.

[6]  P. Striano,et al.  Cryptic chromosome deletions involving SCN1A in severe myoclonic epilepsy of infancy , 2006, Neurology.

[7]  R. Guerrini,et al.  Mosaic SCN1A Mutation in Familial Severe Myoclonic Epilepsy of Infancy , 2006, Epilepsia.

[8]  K. Yamakawa,et al.  SCN1A Mutation Mosaicism in a Family with Severe Myoclonic Epilepsy in Infancy , 2006, Epilepsia.

[9]  I. Scheffer,et al.  A new molecular mechanism for severe myoclonic epilepsy of infancy: Exonic deletions in SCN1A , 2006, Neurology.

[10]  L. Lagae,et al.  Microdeletions involving the SCN1A gene may be common in SCN1A‐mutation‐negative SMEI patients , 2006, Human mutation.

[11]  Ian M. Morison,et al.  The imprinted gene and parent-of-origin effect database now includes parental origin of de novo mutations , 2005, Nucleic Acids Res..

[12]  J. Crow.  Age and sex effects on human mutation rates: an old problem with new complexities. , 2006, Journal of radiation research.

[13]  J. Roger,et al.  Epileptic Syndromes in Infancy, Childhood and Adolescence , 2005 .

[14]  Steven Petrou,et al.  SCN1A mutations and epilepsy , 2005, Human mutation.

[15]  S. Seri,et al.  Idiopathic epilepsies with seizures precipitated by fever: clinical and genetic study of 132 patients , 2005 .

[16]  H. Oguni,et al.  Severe myoclonic epilepsy in infancy: Dravet syndrome. , 2005, Advances in neurology.

[17]  A. V. D. van den Ouweland,et al.  Paternal origin of FGFR3 mutations in Muenke-type craniosynostosis , 2004, Human Genetics.

[18]  R M Gardiner,et al.  Sodium channel α1-subunit mutations in severe myoclonic epilepsy of infancy and infantile spasms , 2003, Neurology.

[19]  Elizabeth A. Thiele,et al.  SNP identification, haplotype analysis, and parental origin of mutations in TSC2 , 2002, Human Genetics.

[20]  L. Lagae,et al.  De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. , 2001, American journal of human genetics.

[21]  P. Huppke,et al.  MECP2 mutations in sporadic cases of Rett syndrome are almost exclusively of paternal origin. , 2001, American journal of human genetics.

[22]  I. Scheffer,et al.  Neuronal sodium-channel alpha1-subunit mutations in generalized epilepsy with febrile seizures plus. , 2001, American journal of human genetics.

[23]  J. Chelly,et al.  Parental origin of de novo MECP2 mutations in Rett syndrome , 2001, European Journal of Human Genetics.

[24]  Rivka L. Glaser,et al.  Paternal origin of FGFR2 mutations in sporadic cases of Crouzon syndrome and Pfeiffer syndrome. , 2000, American journal of human genetics.

[25]  C. Lewis,et al.  Mutation rates in humans. I. Overall and sex-specific rates obtained from a population study of hemophilia B. , 1999, American journal of human genetics.

[26]  R. Ljung,et al.  Origin of mutation in sporadic cases of haemophilia A , 1999, British journal of haematology.

[27]  A. Munnich,et al.  Mutations in fibroblast growth-factor receptor 3 in sporadic cases of achondroplasia occur exclusively on the paternally derived chromosome. , 1998, American journal of human genetics.

[28]  Steven A. Wall,et al.  Exclusive paternal origin of new mutations in Apert syndrome , 1996, Nature Genetics.

[29]  B. Zbar,et al.  Molecular analysis of de novo germline mutations in the von Hippel-Lindau disease gene. , 1995, Human molecular genetics.

[30]  D. J. Driscoll,et al.  Sex difference in methylation of single-copy genes in human meiotic germ cells: Implications for X chromosome inactivation, parental imprinting, and origin of CpG mutations , 1990, Somatic cell and molecular genetics.

[31]  C. Mathew,et al.  Paternal origin of new mutations in Von Recklinghausen neurofibromatosis , 1990, Nature.